NCT01043887View on ClinicalTrials.gov

Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)

PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Healthy VolunteersHepatic Insufficiency

Interventions

DRUG

ridaforolimus

single oral dose administration 10 mg ridaforolimus

Sponsors

Collaborators (1)

Ariad Pharmaceuticals

All Listed Sponsors

collaborator

Ariad Pharmaceuticals

INDUSTRY

lead

Merck Sharp & Dohme LLC

INDUSTRY